Search

everythinglearnresearchcommunity

for

Search:↓

Sonidegib and vismodegib are similarly effective for advanced basal cell carcinoma, but sonidegib might have a slightly better safety profile.

PROTACs offer a new, precise way to treat cancer by breaking down harmful proteins.

New treatments targeting the Hedgehog pathway can help treat advanced skin cancer but may have side effects and their effectiveness in early stages is unknown.

A six-drug treatment for metastatic breast cancer showed promising results with low side effects, especially in premenopausal women.

Recognizing and managing skin side effects from chemotherapy improves patient quality of life and treatment success.

Cancer prevention has advanced significantly, with some strategies proving successful.

Erlotinib can cause persistent excessive hair growth.

PRMT5 inhibitors effectively fight adenoid cystic carcinoma in salivary glands.

CXCR2 in skin cells promotes tumor growth.

The combination of TACE and Donafenib is effective and tolerable for treating unresectable liver cancer.

Different types of skin gland tumors have unique genetic traits, which can guide personalized treatments.

Enhancing immune response can improve cancer treatment effectiveness.

Loss of TET2 increases the risk of skin and oral cancer.

Cetirizine is effective and safe for treating various allergies, with personalized dosing improving its use.

Tumor-targeted drug carriers can improve chemotherapy precision and reduce side effects.

New melanoma treatments can cause skin side effects, including skin cancer and rashes, but combining treatments may reduce these risks.

Identical p53 gene mutations in different cancers suggest the need for careful treatment.

Ritlecitinib helps regrow hair in people with alopecia totalis and universalis and is safe to use.

Antizyme reduces tumor growth and normalizes skin cell development affected by MEK.

Upadacitinib may help treat difficult cases of systemic lupus erythematosus.

Rituximab leads to longer remission and fewer side effects than cyclophosphamide.

The PTH-CBD injection improved hair regrowth better than the daily ruxolitinib pill in mice.

A scalp-cooling system effectively prevents hair loss in breast cancer patients treated with eribulin.

Targeted cancer therapies often cause skin side effects, needing dermatologist care.

Talazoparib is more effective than standard chemotherapy for advanced breast cancer with BRCA mutations.

Rituximab can cause skin issues, but baricitinib may help improve them.

Vaccines and targeting TrxR variants can help prevent cancer and reduce metastasis.

BI 2536 had limited effectiveness against several advanced cancers and caused significant side effects.

Ablative fractional laser treatment nearly matches the gene reduction effects of topical vismodegib in skin cancer.